Spring Bank Ph CS (SBPH) Stock Price & Overview

NASDAQ:SBPH

Current stock price

1.21
0 (0%)
At close:
1.22
+0.01 (+0.83%)
After Hours:

The current stock price of SBPH is 1.21 null. Today SBPH is down by 0%. In the past month the price decreased by -4.72%. In the past year, price decreased by -59.8%.

SBPH Key Statistics

52-Week Range0.8 - 4.8
Current SBPH stock price positioned within its 52-week range.
1-Month Range0.971 - 1.54
Current SBPH stock price positioned within its 1-month range.
Market Cap
20.893M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-1.74
Dividend Yield
N/A

SBPH Stock Performance

Today
0%
1 Week
-9.02%
1 Month
-4.72%
3 Months
-12.95%
Longer-term
6 Months -25.77%
1 Year -59.80%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

SBPH Stock Chart

Spring Bank Ph CS / SBPH Daily stock chart

SBPH Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SBPH. When comparing the yearly performance of all stocks, SBPH is a bad performer in the overall market: 97.11% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
SBPH Full Technical Analysis Report

SBPH Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SBPH. SBPH has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SBPH Full Fundamental Analysis Report

SBPH Earnings

Next Earnings DateN/A
Last Earnings DateN/A
SBPH Earnings History

SBPH Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y4.76%
Revenue Next YearN/A
SBPH Forecast & Estimates

SBPH Financial Highlights

Over the last trailing twelve months SBPH reported a non-GAAP Earnings per Share(EPS) of -1.74. The EPS decreased by -8.07% compared to the year before.


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-27.52M
Industry RankSector Rank
PM (TTM) N/A
ROA -100.99%
ROE N/A
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-35.71%
Sales Q2Q%N/A
EPS 1Y (TTM)-8.07%
Revenue 1Y (TTM)N/A
SBPH financials

SBPH Ownership

Ownership
Inst Owners16.31%
Shares17.27M
Float12.83M
Ins Owners5.32%
Short Float %N/A
Short RatioN/A
SBPH Ownership

About SBPH

Company Profile

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.

Company Info

Spring Bank Ph CS

35 PARKWOOD DRIVE SUITE 210

HOPKINTON MA 01748

CEO: Martin Driscoll

Phone: 508-473-5993

Spring Bank Ph CS / SBPH FAQ

What does SBPH do?

Spring Bank Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of therapeutics using its proprietary small molecule nucleic acid hybrid chemistry platform. The company is developing SB 9200, for the treatment of viral diseases, including hepatitis B virus. Spring Bank Pharmaceuticals, Inc. is based in Hopkinton, United States.


What is the current price of SBPH stock?

The current stock price of SBPH is 1.21 null.


What is the dividend status of Spring Bank Ph CS?

SBPH does not pay a dividend.


What is the ChartMill rating of Spring Bank Ph CS stock?

SBPH has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is the Price/Earnings (PE) ratio of Spring Bank Ph CS (SBPH)?

Spring Bank Ph CS (SBPH) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.74).


Can you provide the market cap for Spring Bank Ph CS?

Spring Bank Ph CS (SBPH) has a market capitalization of 20.89M null. This makes SBPH a Nano Cap stock.